Follicular Lymphoma  >>  PPI 2458  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PPI 2458 / GSK
NCT00100347: Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors

Terminated
1
45
US
PPI-2458
PRAECIS Pharmaceuticals Inc.
Non-Hodgkin's Lymphoma,, Solid Tumors
 
07/07

Download Options